Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Prodrugs01:30

Prodrugs

2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.3K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

385
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
385
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

443
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
443

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DKK3-CKAP4 signaling drives fibroimmune remodeling and hair follicle miniaturization in androgenetic alopecia.

Theranostics·2026
Same author

Off‑the‑shelf, engineered non-living stem cell strategy for advancing cellular therapies.

Nature biomedical engineering·2026
Same author

Venlafaxine reverses chemotherapy-induced alopecia through epithelial and dermal reprogramming at single-cell resolution.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Insights into the context-dependent immunological roles of the CXCL12-CXCR4 axis in alopecia.

Frontiers in immunology·2026
Same author

Poly-D,L-Lactic Acid Filler Restores Hair Thickness and Shine by Ameliorating Age-Associated Follicular Decline.

International journal of molecular sciences·2026
Same author

Poly‑D,L‑lactic acid (PDLLA) scalp microinjection protocol with optional light microneedling priming for non‑scarring alopecia: A prospective pilot case series.

JPRAS open·2026

Related Experiment Video

Updated: May 12, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

8.9K

Recent Advances in Drug Development for Hair Loss.

Jino Kim1, Seung-Yong Song2, Jong-Hyuk Sung3

  • 1New Hair Institute, Seoul 06034, Republic of Korea.

International Journal of Molecular Sciences
|May 7, 2025
PubMed
Summary

New hair loss treatments focus on targeted therapies like antibody and cell-based options to overcome the limitations of current drugs. These innovations promise more effective hair restoration and improved quality of life for patients.

Keywords:
antibody therapydrug developmenthair lossstem cell therapy

More Related Videos

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.0K
Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration
10:09

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration

Published on: February 28, 2013

13.6K

Related Experiment Videos

Last Updated: May 12, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

8.9K
Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.0K
Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration
10:09

Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration

Published on: February 28, 2013

13.6K

Area of Science:

  • Dermatology and Regenerative Medicine
  • Pharmacology and Drug Discovery

Background:

  • Hair loss disorders affect millions globally, significantly impacting quality of life.
  • Current treatments like minoxidil and finasteride have limited efficacy.
  • There is a critical need for novel, targeted therapeutic solutions for hair loss.

Purpose of the Study:

  • To review recent advancements in hair loss drug discovery.
  • To explore the potential of small-molecule inhibitors, biologics, and stem cell-based therapies.
  • To highlight future directions in therapeutic development for hair loss disorders.

Main Methods:

  • Literature review of current research in hair loss drug discovery.
  • Analysis of molecular mechanisms underlying hair follicle regulation.
  • Evaluation of emerging therapeutic modalities including antibody and cell-based treatments.

Main Results:

  • Small-molecule inhibitors, biologics, and stem cell therapies represent key areas of innovation.
  • Antibody therapies offer precise targeting of molecular pathways involved in hair growth.
  • Cell-based therapies, such as stem cell transplantation, show promise for hair follicle regeneration.

Conclusions:

  • Next-generation therapeutics have the potential to transform hair loss management.
  • Future drug development should prioritize antibody and cell-based therapies for enhanced efficacy.
  • These advanced approaches address limitations of existing treatments and offer new avenues for hair restoration.